News and Trends 12 Dec 2024
Top biotech deals of November 2024
November has seen a variety of biotech deals take place to advance therapies across different stages in development.
Small molecules
- Latest Posts
In Depth 4 Dec 2024
Idiopathic pulmonary fibrosis: Refoxy, Boehringer, Insilico, and more on the hunt for curative treatments
There is a lot of research going on in the therapeutic field of idiopathic pulmonary fibrosis, in the hope that more treatments reach patients sooner.
In Depth 27 Nov 2024
Charcot–Marie–Tooth disease: what’s going on in the clinical field?
In this article, we take a look at the various treatments in development to address the unmet needs of people with Charcot–Marie–Tooth disease.
Best in Biotech 14 Nov 2024
8 biotech companies advancing new treatments for breast cancer in 2024
Delve into the diverse landscape of breast cancer treatment with nine biotech companies currently developing new treatments.
In Depth 13 Nov 2024
Sleep apnea: biotechs snore points in the therapeutic space
Therapeutic strides in biotech are proving to help address different stages of the sleep apnea.
News and Trends 4 Nov 2024
Top biotech deals of October 2024
Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in October 2024.
ADVERTISEMENT
ADVERTISEMENT
News and Trends 15 Oct 2024
Booster launches to treat neurodegenerative diseases with proteasome activation
Discover Booster Therapeutics’ novel proteasome activation approach to neurodegenerative diseases as it launches with $15 million.
Podcast 10 May 2024
Cytokinetics’ cardiovascular pipeline beats strong
Discover Cytokinetics’ groundbreaking cardiovascular treatments, including heart drug aficamten, in our latest podcast with CEO Robert Blum.
In Depth 9 May 2024
BTK inhibitors: can these drugs tackle cancer and autoimmunity?
BTK inhibitors were first approved over a decade ago to treat a rare blood cancer. Now, they are in the running to treat a host of autoimmune diseases.
In Depth 17 Apr 2024
Small but mighty: The role of small-molecule drugs in disease treatment
Find out more about small-molecule drugs, including how they work and what their advantages and disadvantages are.
In Depth 27 Mar 2024
Are new treatments for multiple sclerosis on the horizon?
As the wait for new multiple sclerosis treatments continue, here are some ongoing clinical trials that hold promise.
In Depth 25 Mar 2024
Beyond Wegovy: Could Novo Nordisk’s new experimental weight loss pill be even better?
Discover how Novo Nordisk’s new experimental obesity pill, amycretin, could be even more efficient for weight loss than Wegovy.
ADVERTISEMENT
